SRRK Q3 2022 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$2M

Operating Income

-$44M

Net Income

-$43M

EPS (Diluted)

$-0.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$27M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$390M

Total Liabilities

$97M

Stockholders' Equity

$293M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$5M	-100.0%
Gross Profit	-$2M	-$26M	+90.4%
Operating Income	-$44M	-$37M	-18.3%
Net Income	-$43M	-$38M	-15.4%